|
Volumn 90, Issue 8, 2015, Pages E149-E151
|
Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
ERYTHROPOIETIN;
IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
RITUXIMAB;
STEROID;
IMMUNOLOGIC FACTOR;
LENALIDOMIDE;
MONOCLONAL ANTIBODY;
THALIDOMIDE;
AUTOIMMUNE HEMOLYTIC ANEMIA;
BLOOD TRANSFUSION;
COOMBS TEST;
DISEASE SEVERITY;
HEMOGLOBINURIA;
HEMOLYSIS;
HUMAN;
LETTER;
LOW DRUG DOSE;
LUNG EMBOLISM;
MORTALITY;
PLASMAPHERESIS;
PRIORITY JOURNAL;
REMISSION;
RETICULOCYTOPENIA;
SPLENECTOMY;
TREATMENT RESPONSE;
ANALOGS AND DERIVATIVES;
ANEMIA, HEMOLYTIC, AUTOIMMUNE;
BLOOD;
CASE REPORT;
DRUG EFFECTS;
ERYTHROCYTE;
PATHOLOGY;
SEVERITY OF ILLNESS INDEX;
TIME TO TREATMENT;
TREATMENT OUTCOME;
ANEMIA, HEMOLYTIC, AUTOIMMUNE;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ERYTHROCYTES;
HEMOLYSIS;
HUMANS;
IMMUNOLOGIC FACTORS;
PLASMA EXCHANGE;
SEVERITY OF ILLNESS INDEX;
SPLENECTOMY;
STEROIDS;
THALIDOMIDE;
TIME-TO-TREATMENT;
TREATMENT OUTCOME;
|
EID: 84937418721
PISSN: 03618609
EISSN: 10968652
Source Type: Journal
DOI: 10.1002/ajh.24047 Document Type: Letter |
Times cited : (38)
|
References (6)
|